基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 生化试剂 激动剂抑制剂 ZD 6474 化合物 Vandetanib hydrochloride
  • 化合物 Vandetanib hydrochloride|T21641|TargetMol

化合物 Vandetanib hydrochloride|T21641|TargetMol

Vandetanib hydrochloride
524722-52-9
13800 50mg 起订
17500 100mg 起订
10600 25mg 起订
上海 更新日期:2025-11-17

TargetMol中国(陶术生物)

VIP4年
联系人:邵小姐
手机:4008200310 拨打
邮箱:marketing@tsbiochem.com

产品详情:

中文名称:
化合物 Vandetanib hydrochloride
英文名称:
Vandetanib hydrochloride
CAS号:
524722-52-9
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
产品类别:
抑制剂
货号:
T21641

Product Introduction

Bioactivity

名称Vandetanib hydrochloride
描述Vandetanib hydrochloride (D6474 hydrochloride) is a potent, orally active inhibitor of VEGFR2/KDR tyrosine kinase activity with IC 50 of 40 nM. Vandetanib hydrochloride also has some additional activity versus the tyrosine kinase activity of VEGFR3/FLT4 ( IC 50 =110 nM) and EGFR/HER1 ( IC 50 =500 nM) [1].
体外活性Vandetanib inhibits VEGFR3 and EGFR with IC 50 of 110 nM and 500 nM, respectively. However, Vandetanib is not sensitive to PDGFRβ, Flt1, Tie-2 and FGFR1 with IC 50 of 1.1-3.6 μM, while almost has no activity against MEK, CDK2, c-Kit, erbB2, FAK, PDK1, Akt and IGF-1R with IC 50 above 10 μM. Vandetanib inhibits VEGF-, EGF- and bFGF-stimulated HUVEC proliferation with IC 50 of 60 nM, 170 nM and 800 nM, with no effect on basal endothelial cell growth. Vandetanib inhibits tumor cell growth with IC 50 of 2.7 μM (A549) to 13.5 μM (Calu-6) [1]. Odanacatib is a weak inhibitor of antigen presentation, measured in a mouse B cell line (IC 50 =1.5±0.4 μM), compared to the Cat S inhibitor LHVS (IC 50 =0.001 μM) in the same assay. Odanacatib also shows weak inhibition of the processing of the MHC II invariant chain protein Iip10 in mouse splenocytes compared to LHVS (minimum inhibitory concentration 1-10 μM versus 0.01 μM, respectively) [2]. Vandetanib suppresses phosphorylation of VEGFR-2 in HUVECs and EGFR in hepatoma cells and inhibits cell proliferation [4].
体内活性Vandetanib (15 mg/kg, p.o.) shows a superior anti-tumor effect than gefitinib in the H1650 xenograft model, and with IC 50 of 3.5±1.2 μM for inhibiting tumor growth [3]. In tumor-bearing mice, vandetanib (50 or 75 mg/kg) suppresses phosphorylation of VEGFR-2 and EGFR in tumor tissues, significantly reduces tumor vessel density, enhances tumor cell apoptosis, suppresses tumor growth, improves survival, reduces number of intrahepatic metastases, and upregulates VEGF, TGF-α, and EGF in tumor tissues [4].
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
关键字Vandetanib hydrochloride | Vandetanib Hydrochloride
相关产品Naringin | Guanidine hydrochloride | Aceglutamide | Cysteamine hydrochloride | Alginic acid | Metronidazole | Dextran sulfate sodium salt (MW 5000) | Hydroxychloroquine | Citric Acid Triammonium | Stavudine | Paeonol | Sodium 4-phenylbutyrate
Vandetanib hydrochloride|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (13年)
注册资本 566.265100万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生化试剂,分子生物学,分子砌块,生物技术服务

化合物 Vandetanib hydrochloride相关厂家报价

内容声明
拨打电话 立即询价